The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre; Roche
Randomized phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with single-agent OV versus (vs) gemcitabine (GEM) and P followed by maintenance with single-agent GEM as first-line chemotherapy (CT) in locally advanced (LA) or metastatic non-small-cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type.
 
Francesco Grossi
No Relationships to Disclose
 
Piotr Jaskiewicz
No Relationships to Disclose
 
Eric Pichon
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Grzegorz Czyzewicz
No Relationships to Disclose
 
Dariusz Kowalski
No Relationships to Disclose
 
Libero Ciuffreda
No Relationships to Disclose
 
Ramon Garcia-Gomez
No Relationships to Disclose
 
Salvatore Caruso
No Relationships to Disclose
 
Joaquim Bosch-Barrera
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Pierre Fabre; Roche
Research Funding - Boehringer Ingelheim
 
Christine Ta Thanh Minh
Employment - Pierre Fabre
Stock and Other Ownership Interests - Pierre Fabre
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Sebastien Henriet
Employment - Pierre Fabre
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Stephanie Gautier
Employment - Pierre Fabre
Stock and Other Ownership Interests - Pierre Fabre
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Helene Hervieu
Employment - Pierre Fabre
Stock and Other Ownership Interests - Pierre Fabre
 
Gilberto Castro
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Merck Sharp & Dohme; Pfizer; Roche; Teva
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Boehringer Ingelheim; Merck Sharp & Dohme; Novartis; Pfizer; Roche